HEALTH● LOWAug 20 · Aug 20, 2026, 12:27 PM
AC Immune gains on early-stage trial data for anti-inflammatory agent
Seeking Alpha Tech
AC Immune's stock gained following the release of early-stage trial data for its anti-inflammatory agent. This news reflects progress in pharmaceutical development and its market impact.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH39m agoFrance reports first human case of Shamonda virus, but says there's no public health riskFrance 24 [en]HEALTH44m agoWhat to eat to have younger-looking skin?BBC AfriqueHEALTH47m agoLA HBCU Xavier University To Open Medical Schoolkfbk.iheart.com · United StatesHEALTH47m agoGetting health insurance from your job will be extra pricey for 2027kimt.com · United States